Curley Joanne 4
4 · Vera Therapeutics, Inc. · Filed Aug 23, 2023
Insider Transaction Report
Form 4
Curley Joanne
Chief Development Officer
Transactions
- Sale
Class A Common Stock
2023-08-21$16.66/sh−1,490$24,817→ 26,962 total
Footnotes (3)
- [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on September 9, 2022.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.87, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022 for 448 shares, and on March 13, 2023 for 1,183 shares.